Fibrin deposition in SLE glomerulonephritis

Area of Science:

• Nephrology
• Pathology
• Immunology

Background:

• Coagulation and fibrinolysis are key in glomerulonephritis pathogenesis.
• Extensive fibrin deposition often signifies severe renal disease, like rapidly progressive glomerulonephritis.
• Current staining methods struggle to differentiate fibrinogen from fibrin and its degradation products.

Purpose of the Study:

• To investigate the presence and significance of cross-linked fibrin in lupus nephritis.
• To evaluate the utility of a monoclonal antibody (DD3B6) for detecting cross-linked fibrin in renal biopsies.
• To correlate cross-linked fibrin presence with disease severity using established grading systems.

Main Methods:

• Analyzed 30 renal biopsies from patients with systemic lupus erythematosus.
• Utilized a monoclonal antibody (DD3B6) to detect cross-linked fibrin.
• Employed anti-fibrinogen and anti-platelet antibodies for comparative staining.
• Assessed disease severity using WHO classification and Austin's Activity and Chronicity Indices.

Main Results:

• Cross-linked fibrin was detected in 3 biopsies using DD3B6.
• Fibrinogen was present in 27 biopsies, but without evidence of intraglomerular coagulation.
• Biopsies with cross-linked fibrin were classified as WHO group IVc.
• Disease severity, by Austin's Index, was not significantly higher in biopsies with cross-linked fibrin compared to others in WHO Group IVc.

Conclusions:

• The monoclonal antibody DD3B6 can identify cross-linked fibrin in renal biopsies.
• Presence of cross-linked fibrin suggests intraglomerular coagulation.
• Cross-linked fibrin may be associated with more severe forms of glomerulonephritis, particularly WHO group IVc lupus nephritis.